Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes?

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue SUPPL. 1, 2009, Pages

  Lameire, Norbert ^a   Van Biesen, Wim ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM; SODIUM;

ARTERIOVENOUS FISTULA; BLOOD VOLUME; BODY COMPOSITION; BODY FLUID; CHEMICAL COMPOSITION; COMPUTER PROGRAM; CONFERENCE PAPER; DIALYSATE; DIFFUSION; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HEMODIAFILTRATION; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; MEMBRANE; MONITOR; ONLINE MONITORING; SURVIVAL; THERMOREGULATION; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR ACCESS;

DIFFUSION OF INNOVATION; EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HUMANS; KIDNEY FAILURE, CHRONIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RENAL DIALYSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 73849083889     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04000609     Document Type: Conference Paper

References (97)

1. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15: 451-457, 1990
2. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50: 1013-1018, 1996
3. Dor A, Pauly MV, Eichleay MA, Held PJ: End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 7: 73-111, 2007
4. de Francisco AL, Pinera C: Challenges and future of renal replacement therapy. Hemodial Int 10[Suppl 1]: S19-S23, 2006
5. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181, 1981
6. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985
7. Laird NM, Berkey CS, Lowrie EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int Suppl S101-S106, 1983
8. Parker TF, Laird NM, Lowrie EG: Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int Suppl S42-S49, 1983
9. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Schulman G: Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 52: 1395-1405, 1997
10. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48: S2-S90, 2006
11. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, Fouque D, Haage P, Konner K, Kooman J, Pizzarelli F, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG guideline on dialysis strategies. Nephrol Dial Transplant 22[Suppl 2]: ii5-ii21, 2007
12. Eloot S, van Biesen W, Dhondt A, Van de Wynkele H, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73: 765-770, 2008
13. Locatelli F, Buoncristiani U, Canaud B, Kohler H, Petitclerc T, Zucchelli P: Haemodialysis with on-line monitoring equipment: Tools or toys? Nephrol Dial Transplant 20: 22-33, 2005
14. Di Filippo S, Manzoni C, Andrulli S, Pontoriero G, Dell'Oro C, La Milia V, Bacchini G, Crepaldi M, Bigi MC, Locatelli F: How to determine ionic dialysance for the online assessment of delivered dialysis dose. Kidney Int 59: 774-782, 2001
15. Lindsay RM, Bene B, Goux N, Heidenheim AP, Landgren C, Sternby J: Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis. Am J Kidney Dis 38: 565-574, 2001
16. Mercadal L, Du Montcel ST, Jaudon MC, Hamani A, Izzedine H, Deray G, Bene B, Petitclerc T: Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculation. Nephrol Dial Transplant 17: 106-111, 2002
17. Maduell F, Vera M, Arias M, Serra N, Blasco M, Bergada E, Fontsere N, Cases A, Campistol JM: Influence of the ionic dialysance monitor on Kt measurement in hemodialysis. Am J Kidney Dis 52: 85-92, 2008
18. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
19. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G: Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 65: 1386-1394, 2004
20. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ: High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 43: 1014-1023, 2004
21. Eloot S, Torremans A, de Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R: Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds. Kidney Int 67: 1566-1575, 2005
22. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Gutzwiller F, Zehnder CE: Estimating phosphate removal in haemodialysis: An additional tool to quantify dialysis dose. Nephrol Dial Transplant 17: 1037-1044, 2002
23. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF: Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 10: 601-609, 1999
24. Fajardo L, Campistrus N, Rios P, Gomez T: Evolution of serum phosphate in long intermittent hemodialysis. Kidney Int Suppl S66-S68, 2003
25. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D: Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 60: 1555-1560, 2001
26. Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt JK: Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. Am J Kidney Dis 40: 1211-1218, 2002
27. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998
28. Pohlmeier R, Vienken J: Phosphate removal and hemodialysis conditions. Kidney Int Suppl 78: S190-S194, 2001
29. Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 15: 58-64, 2000
30. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatori G, Andrikos E, Yavuz A, Crepaldi C, Ronco C: Phosphate kinetics during different dialysis modalities. Blood Purif 23: 83-90, 2005
31. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG: Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis 43: 85-89, 2004
32. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
33. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
34. Jean G, Chazot C, Charra B: Hyperphosphataemia and related mortality. Nephrol Dial Transplant 21: 273-280, 2006
35. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ: From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 24: 217-224, 2009
36. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A: Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61: 2235-2239, 2002
37. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298: 1291-1299, 2007
38. Briggs JP: Evidence-based medicine in the dialysis unit: A few lessons from the USRDS and the NCDS and HEMO Trials. Semin Dial 17: 136-141, 2004
39. National Institutes of Health: Frequent Hemodialysis Clinical Trials. Available at: http://www.niddk.nih.gov/ patient/hemodialysis/hemodialysis.htm. Accessed May 1, 2009
40. Moran J: Technical advances in home dialysis. Adv Chronic Kidney Dis 16: 215-220, 2009
41. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T: A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 129: 701-706, 1985
42. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, Orlandini G: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 50: 1293-1302, 1996
43. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R: Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20: 645-654, 2009
44. Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman HI, Good-kin DA, Gillespie B, Wolfe RA, Held PJ, Port FK: Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 19: 108-120, 2004
45. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ: Cerebrovascular disease in maintenance hemodialysis patients: Results of the HEMO Study. Am J Kidney Dis 47: 131-138, 2006
46. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, Levey AS, Leypoldt JK, Ornt DB, Rocco MV, Schulman G, Schwab S, Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
47. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO study. J Am Soc Nephrol 17: 546-555, 2006
48. Cheung AK, Greene T, Leypoldt JK, Yan G, Allon M, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G: Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 3: 69-77, 2008
49. Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, Klassen P, Port FK: Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69: 2087-2093, 2006
50. Krane V, Krieter DH, Olschewski M, Marz W, Mann JF, Ritz E, Wanner C: Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49: 267-275, 2007
51. Lambie S, Warwick G: Intelligent hemodialysis: Toys or tools? Hemodial Int 11: 834-838, 2007
52. Ronco C, Ghezzi PM, La Greca G: The role of technology in hemodialysis. J Nephrol 12[Suppl 2]: S68-S81, 1999
53. Santos SF, Peixoto AJ: Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 3: 522-530, 2008
54. Mann H, Stiller S: Sodium modeling. Kidney Int Suppl 76: S79-S88, 2000
55. Palmer BF: Individualizing the dialysate in the hemodialysis patient. Semin Dial 14: 41-49, 2001
56. Song JH, Lee SW, Suh CK, Kim MJ: Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 40: 291-301, 2002
57. Song JH, Park GH, Lee SY, Lee SW, Lee SW, Kim MJ: Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 16: 237-246, 2005
58. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van WD, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 119: 671-679, 2009
59. Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, Konner K, Martin-Malo A, Pedrini L, Tattersall J, Tordoir J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG guideline on haemodynamic instability. Nephrol Dial Transplant 22[Suppl 2]: ii22-ii44, 2007
60. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, Chertow GM: Cardiac arrest and sudden death in dialysis units. Kidney Int 60: 350-357, 2001
61. Ritz E, Wanner C: The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 3: 920-929, 2008
62. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238-248, 2005
63. Krane V, Heinrich F, Meesmann M, Olschewski M, Lilienthal J, Angermann C, Stork S, Bauersachs J, Wanner C, Frantz S: Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 4: 394-400, 2009
64. Redaelli B, Locatelli F, Limido D, Andrulli S, Signorini MG, Sforzini S, Bonoldi L, Vincenti A, Cerutti S, Orlandini G: Effect of a new model of hemodialysis potassium removal on the control of ventricular arrhythmias. Kidney Int 50: 609-617, 1996
65. Santoro A, Mancini E, London G, Mercadal L, Fessy H, Perrone B, Cagnoli L, Grandi E, Severi S, Cavalcanti S: Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant 23: 1415-1421, 2008
66. Maggiore Q, Pizzarelli F, Zoccali C, Sisca S, Nicolo F, Parlongo S: Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transplant Assoc 18: 597-602, 1981
67. Santoro A, Mancini E, Canova C, Mambelli E: Thermal balance in convective therapies. Nephrol Dial Transplant 18[Suppl 7]: 41-45, 2003
68. Lopot F, Sulkova S, Fortova M, Nejedly B: Temperature and thermal balance monitoring and control in dialysis. Hemodial Int 7: 177-183, 2003
69. Kaufman AM, Morris AT, Lavarias VA, Wang Y, Leung JF, Glabman MB, Yusuf SA, Levoci AL, Polaschegg HD, Levin NW: Effects of controlled blood cooling on hemodynamic stability and urea kinetics during high-efficiency hemodialysis. J Am Soc Nephrol 9: 877-883, 1998
70. Selby NM, McIntyre CW: A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21: 1883-1898, 2006
71. Raimann J, Liu L, Tyagi S, Levin NW, Kotanko P: A fresh look at dry weight. Hemodial Int 12: 395-405, 2008
72. Charra B, Chazot C, Laurent G, Calemard E, Terrat JC, Vanel T, Jean G, Ruffet M: Clinical assessment of dry weight. Nephrol Dial Transplant 11[Suppl 2]: 16-19, 1996
73. Wizemann V, Schilling M: Dilemma of assessing volume state: The use and limitations of a clinical score. Nephrol Dial Transplant 10: 2114-2117, 1995
74. Aurigemma GP, Gaasch WH: Clinical practice: Diastolic heart failure. N Engl J Med 351: 1097-1105, 2004
75. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A: The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 153: 244-245, 2007
76. Schneditz D, Pogglitsch H, Horina J, Binswanger U: A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis. Kidney Int 38: 342-346, 1990
77. Santoro A, Mancini E, Basile C, Amoroso L, Di GS, Usberti M, Colasanti G, Verzetti G, Rocco A, Imbasciati E, Panzetta G, Bolzani R, Grandi F, Polacchini M: Blood volume controlled hemodialysis in hypotension-prone patients: A randomized, multicenter controlled trial. Kidney Int 62: 1034-1045, 2002
78. Rodriguez HJ, Domenici R, Diroll A, Goykhman I: Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int 68: 854-861, 2005
79. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24: 1574-1579, 2009
80. Ward RA: Worldwide water standards for hemodialysis. Hemodial Int 11: S18-S25, 2007
81. Kjellstrand CA, Kjellstrand P: Beyond ultrapure dialysate: A necessary and achievable goal. Hemodial Int 11: S39-S48, 2007
82. Ledebo I: Clinical benefits of ultrapure dialysis fluid for hemodialysis. Hemodial Int 11: S12-S17, 2007
83. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 12: 1549-1557, 2001
84. Stenvinkel P, Alvestrand A: Inflammation in end-stage renal disease: Sources, consequences, and therapy. Semin Dial 15: 329-337, 2002
85. Stenvinkel P: Inflammation in end-stage renal disease: A fire that burns within. Contrib Nephrol 149: 185-199, 2005
86. Stenvinkel P: New insights on inflammation in chronic kidney disease: Genetic and non-genetic factors. Nephrol Ther 2: 111-119, 2006
87. Navarro MD, Carracedo J, Ramirez R, Madueno JA, Merino A, Rodriguez M, Martin-Malo A, Aljama P: Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients. Nephrol Dial Transplant 22: 3580-3585, 2007
88. Gomila M, Gasco J, Gil J, Bernabeu R, Inigo V, Lalucat J: A molecular microbial ecology approach to studying hemodialysis water and fluid. Kidney Int 70: 1567-1576, 2006
89. Glorieux G, Schepers E, Schindler R, Lemke HD, Verbeke F, Dhondt A, Lameire N, Vanholder R: A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant 24: 548-554, 2009
90. Schindler R, Beck W, Deppisch R, Aussieker M, Wilde A, Gohl H, Frei U: Short bacterial DNA fragments: Detection in dialysate and induction of cytokines. J Am Soc Nephrol 15: 3207-3214, 2004
91. Bossola M, Sanguinetti M, Scribano D, Zuppi C, Giungi S, Luciani G, Torelli R, Posteraro B, Fadda G, Tazza L: Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol 4: 379-385, 2009
92. Canaud B: Online hemodiafiltration: Technical options and best clinical practices. Contrib Nephrol 158: 110-122, 2007
93. Ward RA, Ronco C: Improvements in technology: A path to safer and more effective hemodialysis. Blood Purif 27: 6-10, 2009
94. Canaud B: Effect of online hemodiafiltration on morbidity and mortality of chronic kidney disease patients. Contrib Nephrol 158: 216-224, 2007
95. Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R: Chronic inflammation and mortality in haemodialysis: Effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 23: 2337-2343, 2008
96. Jirka T, Cesare S, Di BA, Perera CM, Ponce P, Richards N, Tetta C, Vaslaky L: Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int 70: 1524-1525, 2006
97. Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapana R, Strippoli GF: The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: A small randomized controlled trial. Am J Kidney Dis 52: 507-518, 2008